Researcher Profile

X. F. Steven Zheng, PhD

Resident Member, Rutgers Cancer Institute of New Jersey

Full Member, Cancer Pharmacology Program

Member since 2005

Academic Appointment

University Professor of Pharmacology
Robert Wood Johnson Medical School
Rutgers, The State University of New Jersey


Co-Leader, Cancer Pharmacology Research Program at the Rutgers Cancer Institute of New Jersey

Research Interests

  • Growth is the process whereby cells accumulate mass, which determines the sizes of cells, organs and organisms. Deregulation of growth is directly linked to human diseases from cancer to aging. Specifically, our current focus is on the target of rapamycin (TOR) protein, a highly conserved phosphatidylinositol kinase-related kinase (PIKK) and a central controller of cell growth. We are interested in dissecting the basic signal transduction mechanisms by TOR and in understanding the mechanisms by which cancer cells resist rapamycin and rapamycin analogs. We hope to ultimately develop more effective therapeutics against human cancer.

Selected Publications

The content for this Researcher Profile is maintained by Paul Novembre (

effective 3/6/17




precision medicine at Rutgers Cancer Institute




Donate Now








Proud member of
Big Ten Cancer Research Consortium



Rutgers Health